R&D, strategic alliances and shareholder value in biotech industry.
The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" v...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Published: |
2008
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/7721 |